...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Corp. Commences Operations

Hi Koo.

I'm not to good at this stuff so I have a silly question. Who will the shareholders of Zenith Capital be?

People like me will hold shares in Zenith Epigenetics. If under the restructuring I'll (we) also hold shares in Zenith Capital then that is good IMHO.

My apologies for asking this question because I'm sure it was discussed previously in terms of the value assigned to each type of share.

Regards

Toinv

Share
New Message
Please login to post a reply